Sec. 2. Trans-NIH Awards for Early-Career Pediatric Researchers
399 words·~2 min read·
/bill/117/hr/3773/ih/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Part G of title IV of the Public Health Service Act ( 42 U.S.C. 288 et seq. ) is amended by adding at the end the following new section: The Director of the NIH shall make awards to outstanding scientists, including physician-scientists, to support early-career researchers focusing on pediatric research, including basic, clinical, translational, or pediatric pharmacological research. In carrying out subsection (a), the Director of NIH may prioritize the issuance of awards to applicants who— are individual researchers presenting qualifying applications and representing populations that have been historically underrepresented in pediatric medical research, including women and underrepresented racial minorities; or are institutions of higher education that are eligible to receive funds under part A or B of title III of the Higher Education Act of 1965, part A or B of title V of such Act, or subpart 4 of part A of title VII of such Act, or research institutions partnering with such institutions of higher education to offer programs to support early-career pediatric researchers.
In carrying out subsection (a), the Director of NIH, in consultation with the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the directors of other national research institutes and national centers that participate within the Trans-NIH Pediatric Research Consortium, shall— establish priority research topic areas, informed by external stakeholders, including research institutions, research societies, patient organizations, and industry; and consider opportunities to align such priority pediatric research topic areas with current and future priorities of the National Institutes of Health, including— pediatric and adolescent mental and behavioral health, including addiction medicine; childhood cancer; precision medicine, genetics, and genomics; rare diseases and disorders, such as sickle cell disease, and other diseases and disorders with significant unmet training needs; and fetal, placental, and neonatal development.
The Director of NIH— shall require recipients of awards under this section to use such awards to support pediatric research activities, including costs associated with laboratory staff and other costs associated with the conduct of research; and may allow recipients of awards under this section to use such awards for costs associated with receiving guidance and training from senior researchers and mentors, as necessary to help such recipients reach a state of research independence, including conferences and other meeting participation.
Awards made under this section shall be used to supplement, and not supplant, other funding for pediatric research and pediatric training. .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 2
Trans-NIH Awards for Early-Career Pediatric Researchers
Cites 1Cited by 0 across 0 sources